153 related articles for article (PubMed ID: 23939151)
1. Well-differentiated adenocarcinoma-bronchioloalveolar carcinoma-in situ adenocarcinoma: a conundrum.
Weissferdt A; Kalhor N; Moran CA
Adv Anat Pathol; 2013 Sep; 20(5):347-51. PubMed ID: 23939151
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
3. [The new classification of lung adenocarcinoma].
Petersen I
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S16-24. PubMed ID: 24150851
[TBL] [Abstract][Full Text] [Related]
4. Assessment of invasion in lung adenocarcinoma classification, including adenocarcinoma in situ and minimally invasive adenocarcinoma.
Borczuk AC
Mod Pathol; 2012 Jan; 25 Suppl 1():S1-10. PubMed ID: 22214965
[TBL] [Abstract][Full Text] [Related]
5. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
Strand TE; Rostad H; Strøm EH; Hasleton P
Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
8. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Ishikawa Y; Wistuba I; Flieder DB; Franklin W; Gazdar A; Hasleton PS; Henderson DW; Kerr KM; Nakatani Y; Petersen I; Roggli V; Thunnissen E; Tsao M
Arch Pathol Lab Med; 2013 May; 137(5):685-705. PubMed ID: 22913371
[TBL] [Abstract][Full Text] [Related]
10. [New WHO classification of lung adenocarcinoma and preneoplasia].
Lantuejoul S; Rouquette I; Brambilla E; Travis WD
Ann Pathol; 2016 Jan; 36(1):5-14. PubMed ID: 26791238
[TBL] [Abstract][Full Text] [Related]
11. 'Bronchioloalveolar carcinoma': is the term really dead? A critical review of a new classification system for pulmonary adenocarcinomas.
Xu L; Tavora F; Burke A
Pathology; 2012 Oct; 44(6):497-505. PubMed ID: 22990278
[TBL] [Abstract][Full Text] [Related]
12. Bronchioloalveolar carcinoma and the significance of invasion: predicting biologic behavior.
Schmidt L; Myers J
Arch Pathol Lab Med; 2010 Oct; 134(10):1450-4. PubMed ID: 20923299
[TBL] [Abstract][Full Text] [Related]
13. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive adenocarcinomas of the lung.
Dacic S
Adv Anat Pathol; 2009 May; 16(3):166-71. PubMed ID: 19395880
[TBL] [Abstract][Full Text] [Related]
15. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
16. Subtyping lung adenocarcinoma according to the novel 2011 IASLC/ATS/ERS classification: correlation with patient prognosis.
Okada M
Thorac Surg Clin; 2013 May; 23(2):179-86. PubMed ID: 23566969
[TBL] [Abstract][Full Text] [Related]
17. Bronchioloalveolar carcinoma is really carcinoma in situ.
Goyal A; Chen S
Arch Pathol Lab Med; 2008 Oct; 132(10):1548. PubMed ID: 18834206
[No Abstract] [Full Text] [Related]
18. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
19. Tumour growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma.
Heikkilä L; Mattila P; Harjula A; Suomalainen RJ; Mattila S
Ann Chir Gynaecol; 1985; 74(5):210-4. PubMed ID: 3002226
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification.
Kerr KM
J Clin Pathol; 2013 Oct; 66(10):832-8. PubMed ID: 23564952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
